Melmoth Patterson
Family Medicine · Laurens, SCNPI 1558464792
Payments from drug & device makers
Across 220 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$451
- AstraZeneca$421
- GSK$390
- Otsuka America Pharmaceutical, Inc.$275
- Novartis$240
- Lilly USA, LLC$221
- plus $2K from 41 others
What the payments were for
- Food & beverage$3,54499%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,575 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 185 | $219,433 |
| EliquisApixaban | 374 | $176,045 |
| JardianceEmpagliflozin | 319 | $175,130 |
| RexultiBrexpiprazole | 99 | $75,467 |
| FarxigaDapagliflozin Propanediol | 143 | $72,025 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 80 | $56,934 |
| MyrbetriqMirabegron | 163 | $51,233 |
| MounjaroTirzepatide | 45 | $46,665 |
| EntrestoSacubitril/Valsartan | 137 | $45,557 |
| JanumetSitagliptin Phos/Metformin Hcl | 65 | $39,795 |
| JanuviaSitagliptin Phosphate | 29 | $32,095 |
| XareltoRivaroxaban | 113 | $31,428 |
| LinzessLinaclotide | 38 | $29,349 |
| Breo ElliptaFluticasone/Vilanterol | 67 | $28,658 |
| TrulicityDulaglutide | 29 | $27,164 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $451 | $219,433185 claims |
| PfizerEliquis, Prempro, Premarin | $71 | $187,723436 claims |
| Boehringer IngelheimJardiance | $70 | $175,130319 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $390 | $85,592147 claims |
| MerckJanumet, Januvia, Janumet Xr | $18 | $83,857122 claims |
| AstraZenecaFarxiga, Symbicort | $421 | $79,053165 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $275 | $75,46799 claims |
| Lilly USA, LLCMounjaro, Trulicity | $221 | $73,82974 claims |
| Astellas Pharma US IncMyrbetriq | $31 | $51,233163 claims |
| NovartisEntresto | $240 | $45,557137 claims |
| AbbVieLinzess, Restasis | $152 | $36,10049 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $65 | $10,69718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Laurens
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.